Drug factory · FDA FEI 3013914542

Optimus Pharma Private Limited

Plot No. 73/B & 73/B/2, EPIP, Pashamylaram (V), Patancheru (M), Sangareddy, Telangana, 502307 India, Hyderabad, India

India: 1

Problems found, fixed voluntarily at FDA's last inspection, Oct 1, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2019: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Aminocaproic AcidMakes it, tests it and labels it Optimus Pharma Private Limited, Rising Pharma Holdings, Inc., Seton Pharmaceuticals, LLC 73216-110, 73216-111, 16571-326 +3
CabergolineMakes it Somerset Therapeutics, LLC 70069-824
FluvoxamineMakes it Upsher-Smith Laboratories, Inc. 0832-6025, 0832-6026
KetorolacMakes it Atnahs Pharma Us Limited, Bionpharma Inc. 72684-006, 69452-275
PenicillamineMakes it Breckenridge Pharmaceutical, Inc. 51991-974
ProchlorperazineMakes it Bionpharma Inc. 69452-309, 69452-310
RopiniroleMakes it, tests it and labels it Bionpharma Inc. 69452-356, 69452-357, 69452-358 +4
TioproninMakes it Cycle Pharmaceuticals Ltd., Torrent Pharma, Inc. 70709-121, 70709-123, 13668-691 +1

FDA inspection history

EndedResultProgramProblems noted
Oct 1, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 23, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 6, 2019No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture.